July 3, 2017 by Chain Drug Review
McKesson, McKesson Canada, Rexall Health, Rx Drug Mart, Uniprix
2017, Issue 07-03-2017, Issues, News
ST. LAURENT, Quebec — McKesson Corp. is selling 27 Rexall drug stores to Rx Drug Mart under a consent agreement with the Competition Bureau of Canada for its $2.2 billion (Canadian) acquisition of Rexall Health. The Competition Bureau said last month that it has approved Rx Drug Mart, a Toronto-based independent pharmacy network, as the
June 12, 2017 by Chain Drug Review
Competition Bureau of Canada, Katz Group Canada, McKesson, Rexall drug stores, Rexall Health, Rx Drug Mart, Uniprix
Business, Leading Headlines, Retail News
OTTAWA — McKesson Corp. is selling 27 Rexall drug stores to Rx Drug Mart Inc. under a consent agreement with the Competition Bureau of Canada for its $2.2 billion acquisition of Rexall Health. The Competition Bureau said Friday that it has approved Rx Drug Mart, a Toronto-based independent pharmacy network, as the buyer of the
June 5, 2017 by Jeffrey Woldt and Chain Drug Review
Celesio, CoverMyMeds, Health Mart, Jeffrey Woldt, McKesson, Paul Julian, Rexall Health, Uniprix
2017, Issue 06-05-2017, Issues, Opinion
Members of McKesson Corp.’s senior management know what it takes to be a major player in the global health care marketplace, and they are moving decisively to ensure that going forward the company remains a dominant force in the sector. McKesson in recent years has made a number of strategic acquisitions that deepen and extend
January 16, 2017 by Mark Baumgartner and Chain Drug Review
Domenic Pilla, John Hammergren, Jürgen Schreiber, McKesson, McKesson Canada, Paul Julian, Rexall Health, Shoppers Drug Mart
2017, Issue 01-16-2017, Issues, News
TORONTO — Domenic Pilla has been appointed chief executive officer of McKesson Canada. Pilla now guides Canada’s largest distributor of pharmaceuticals and medical supplies and oversees the integration of Rexall Health, which McKesson Canada acquired in late December. McKesson Canada picked up about 470 retail pharmacies in the Rexall deal. Pilla reports to Paul Julian,
December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
December 14, 2016 by Chain Drug Review
Competition Bureau of Canada, Katz Group Canada, McKesson, Paul Julian, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO — McKesson Corp. has been given the green light from the Competition Bureau of Canada to finalize its $2.2 billion acquisition of drug chain Rexall Health. McKesson said Wednesday that under the consent agreement it signed with the bureau, it must sell a total of 26 Rexall drug stores in Alberta, British Columbia,
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News
TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 14, 2016 by Jeffrey Woldt and Chain Drug Review
Canadian pharmacy market, Jean Coutu Group, Jeffrey Woldt, Katz Group, Lawtons Drugs, Loblaw, McKesson, Rexall Health, Shoppers Drug Mart, Sobeys
2016, Issue 03-14-2016, Issues, Leading Headlines, Opinion
McKesson Corp.’s agreement to acquire Rexall Health from Katz Group is notable in several respects. The transaction alters the balance of power in the Canadian pharmacy market. In addition, it offers confirmation, if any were needed, of the relentless drive among major players in the sector to increase their scale and, in the process,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
February 22, 2016 by Mark Baumgartner and Chain Drug Review
Ateb Canada, Frank Sheppard, Jürgen Schreiber, medication synchronization, OneStopMeds, Rexall Health, Time My Meds
2016, Issue 02-22-2016, Issues, News
MISSISSAUGA, Ontario — Rexall Health and Ateb Canada Ltd. are partnering on a medication synchronization program aimed at improving medication adherence and health outcomes for patients with multiple chronic conditions. The service, OneStopMeds, uses Ateb technology to help Rexall’s pharmacists coordinate a patient’s prescriptions so each is refilled on the same day of the month,
January 25, 2016 by Chain Drug Review
Ateb, Frank Sheppard, Jürgen Schreiber, medication synchronization, OneStopMeds, Rexall, Rexall Health, Time My Meds
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
MISSISSAUGA, Ontario — Rexall has launched a medication synchronization program for 445 of its pharmacies across Canada. Called OneStopMeds, the med sync program is powered by Ateb’s Time My Meds solution. Rexall said Monday that it’s the first retail pharmacy in Canada to offer this service to patients in multiple provinces. To participate in the
October 12, 2015 by Geoff Walden and Chain Drug Review
chain drug industry, CVS Health, Empire Co., Express Scripts, Jean Coutu Group, Metro Inc., Rexall Health, Rite Aid, Shoppers Drug Mart, Stefano Pessina, Target Corp., Walgreens Boots Alliance, Walmart
2015, Business, Issue 10-12-2015, Issues, Leading Headlines, News, Retail News
NEW YORK — As much as the chain drug industry has consolidated, there is room for more mergers and acquisitions. That’s evident from the M&A speculation swirling about the sector in the U.S. and Canada, as well as recent activity. Lending credibility to the speculation is none other than Walgreens Boots Alliance (WBA) chief executive
June 15, 2015 by Chain Drug Review
Daryl Katz, Jürgen Schreiber, Katz Group, Rexall Health, Shoppers Drug Mart
2015, Issue 06-15-2015, News
EDMONTON, Alberta — Canada’s Rexall/Rexall Pharma Plus drug chain has a new chief executive officer and a new operating structure. Former Shoppers Drug Mart chief executive Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Plans call for Schreiber, who joins the company from Edcon Group, South
May 28, 2015 by John Schultz and Chain Drug Review
Claimsecure, Daryl Katz, Edcon Group, Jürgen Schreiber, Katz Group, Medicentres Canada, Rexall, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News
EDMONTON, Alberta – Former Shoppers Drug Mart chief executive officer Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Rexall said Thursday that Schreiber, who joins the company from Edcon Group, South Africa’s largest nonfood retailer, is slated to take the helm as CEO in August. In